Mood Disorders, ADHD and Obesity: Converging Neuroscience, Clinical Overlap and Novel Treatments

Date: February 9, 2019

Location: Mississauga, Ontario, Canada

This archived, self-directed learning activity is available for personal viewing and is based on the live event held in online on February 9th 2019.  The program involved a multidisciplinary faculty of clinician researchers from SUNY Upstate Medical University, Mount Sinai Hospital, and the University of Toronto. 

This program is intended for family physicians, psychiatrists, endocrinologists, and allied health professionals, who provide care for people with mood disorders, ADHD and/or diabetes.

Learning Objectives

1. Become familiar with the latest scientific evidence linking obesity and diabetes to CNS disease

2. Understand how depression and ADHD can contribute to obesity and diabetes

3. Learn about state-of-the-art treatments for ADHD, depression, obesity and diabetes

The Panel
rsm.png

Dr. Roger McIntyre

MD, FRCPC

Professor of Psychiatry and Pharmacology 
Executive Director, BCDF
Head, Mood Disorders Psychopharmacology Unit 
University of Toronto ​

Talk 1: Major Depressive Disorder and Bipolar Disorder 

Talk 2: Obesity Inflammation and the Brain: Implications for Bidirectional Metastasis and Metaboptosis

Screen Shot 2018-06-18 at 12.14.57 PM.pn

Dr. Harpreet Bajaj

MD, MPH, ECNU, FACE

Endocrinologist and Epidemiologist, LMC Diabetes & Endocrinology, Brampton, ON

Research Associate, Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto

Co-Chair, Marketing & Communication, Diabetes Canada National Professional Section

Columnist and blogger, www.medscape.com

Founder, “STOP Diabetes” Foundation Inc.

Talk: The Impact of Diabetes Management on Mood Disorders & ADHD 

Picture1.png

Dr. Thomas Schwarts

MD

Professor of Psychiatry & Behavioral Sciences
SUNY Upstate Medical University, Syracuse, NY

Talk: Adult ADHD: Clinical Challenges and Treatment Options